Âîòðèåíò (Votrient) òàáë. ïî 400 ìã ôë. ¹30, GlaxoSmithKline Export (Âåëèêîáðèòàíèÿ)
Óêðà¿íà / Êè¿â
Âîòðèåíò (Votrient) òàáë. ïî 400 ìã ôë. ¹30, GlaxoSmithKline Export (Âåëèêîáðèòàíèÿ)
Ñåðòèôèêàò êà÷åñòâà îò ïðîèçâîäèòåëÿ â íàëè÷èè.
Îñòàòîê 25 òàáëåòîê.
Ñðîê ãîäíîñòè 04.2018.
- Íåðóõîì³ñòü
- Àâòî, ìîòî
- Ïðåäìåòè ïîáóòó
- Ïðåäìåòè ðîáîòè
- Ðîáîòà
- Îñîáèñòå æèòòÿ
- Äîçâ³ëëÿ òà â³äïî÷èíîê
- Ïîñëóãè
- ²íòåðíåò òà êîìï'þòåðè
- Õàð÷óâàííÿ
- Ìîíòàæ/Äåìîíòàæ
- Ïîáóòîâèé ðåìîíò
- Ñàíòåõí³êà
- Áóä³âíèöòâî, ðåìîíò
- ³êíà, äâåð³, áàëêîíè
- Âñå äëÿ äà÷³ / çàì³ñüêîãî áóäèíêó
- Ïðèáèðàííÿ ïðèì³ùåíü
- Äèçàéí, ïðîåêòóâàííÿ
- Âèðîáíè÷³
- Øâåéíà ñïðàâà
- Ìåäè÷í³
- Âåòåðèíàðí³
- Áóõãàëòåð³ÿ, àóäèò
- Îõîðîíà
- Þðèäè÷í³
- Ïàðòíåðè ïî á³çíåñó
- Ô³íàíñîâ³
- Îñâ³òí³
- Òðåí³íãè, ïðèâàòí³ óðîêè, êóðñè
- Ïåðåâåçåííÿ
- Ïîë³ãðàô³ÿ, ðåêëàìà
- Óðî÷èñòîñò³
- ³äåî òà ôîòîçéîìêà
- Ïðîêàò
- Êðàñà, Çäîðîâ'ÿ
- Ìàã³ÿ, âîðîæ³ííÿ ³ åêñòðàñåíñè
- Ïñèõîëîã, Ïñèõîëîã³÷íà äîïîìîãà
- Ïåðåêëàäè
- гçíå